Audio

Community Oncology Podcast: Everolimus in ER-positive breast cancer

Plus a review by Dr. Jimmie C. Holland of guidelines for screening patients for distress


 

Dr. David Henry is your audio tour guide to the November 2011 issue of Community Oncology. Issue highlights include Community Translations, which addresses the role of everolimus in treating hormone-resistant ER-positive breast cancer; a review of guidelines for screening cancer patients for distress by Amy E. Lowery and Jimmie C. Holland; and original research on the impact of bone metastases and skeletal-related events on healthcare costs in prostate cancer patients on hormonal therapy by May Hagiwara, et.al. Also, reports from recent oncology meetings and regulatory news from Congress and the FDA.

Recommended Reading

Political Battles Brew Over Breast Density
MDedge Hematology and Oncology
Radiopharmaceuticals: When and How to Use Them to Treat Metastatic Bone Pain
MDedge Hematology and Oncology
Coordination of Care in Breast Cancer Survivors: An Overview
MDedge Hematology and Oncology
Older Women Shortchanged on Gains in Breast Cancer Survival
MDedge Hematology and Oncology
Diversity of Triple-Negative Breast Cancer Complicates Treatment
MDedge Hematology and Oncology
Walking Ability Aids Assessment of Elderly Breast Cancer Patients
MDedge Hematology and Oncology
FDA Revokes Avastin Approval for Breast Cancer
MDedge Hematology and Oncology
Have Your Say on the Avastin Decision
MDedge Hematology and Oncology
Medicare Won't Change Avastin Coverage For Now
MDedge Hematology and Oncology
Mammography: Family History Data Support Yearly Screening
MDedge Hematology and Oncology